RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-769
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0403200; Gene model (P.falciparum): PF3D7_0304600; Gene product: circumsporozoite (CS) protein (CS; CSP)
Details mutation: Endogenous CS replaced by CS of P. galinaceum with SpeI & XhoI sites flanking the repeat region
Phenotype Sporozoite; Liver stage;
Last modified: 22 September 2012, 11:49
  *RMgm-769
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 22393411
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 2.34
Other information parent lineP. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943)
The mutant parasite was generated by
Name PI/ResearcherC. Aldrich; R. Spaccapelo
Name Group/DepartmentDepartment of Experimental Medicine
Name InstituteUniversity of Perugia
CityPerugia
CountryItaly
Name of the mutant parasite
RMgm numberRMgm-769
Principal namePgCSSX clones 1 and 2
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNormal numbers of oocysts and midgut sporozoites (at day 14 post infection). Strongly reduced numbers of salivary gland sporozoites at day 21 p.i. Salivary gland sporozoites are unable to infect mice after intravenous inoculation
Liver stageSalivary gland sporozoites are unable to infect mice after intravenous inoculation
Additional remarks phenotype

Mutant/mutation
In the mutant the endogenous P. berghei  csp (circumsporozoite protein) gene is replaced by the P. gallinaceum csp with introduced SpeI and XhoI sites flanking the repeat region.

Protein (function)
The CS protein is the major protein on the surface of sporozoites and is critical for development of sporozoites within the oocysts and is involved in motility and invasion of both the salivary gland of the mosquito and the liver cells. The protein is also found on the oocyst plasma membrane and on the inner surface of the oocyst capsule. Specific motifs in CS are involved in sporozoite binding to mosquito salivary glands and in sporozoite attachment to heparan sulfate proteoglycans in the liver of the mammalian host. During substrate-dependent locomotion of sporozoites, CS is secreted at the sporozoite anterior pole, translocated along the sporozoite axis and released on the substrate at the sporozoite posterior pole. Following sporozoite invasion of hepatocytes, the CS is released in the host cell cytoplasm.

Phenotype
Normal numbers of oocysts and midgut sporozoites (at day 14 post infection). Strongly reduced numbers of salivary gland sporozoites at day 21 p.i. Sporozoites are not infectious to mice

Additional information
Staining of midgut sporozoites with anti-CSP antibodies showed normal expression,  location. processing and release of the mutated CSP

Figure 1

Figure 1.
Schematic representation of the CS proteins present in each of the four transgenic P. berghei parasite lines generated.
PbCSDHFR parasites carry the wildtype PbCS coding sequence (white boxes, RI and RII indicated with light and dark green respectively)
PgCSSX parasites carry the full PgCS coding sequence (grey boxes, RI and RII indicated with light and dark blue respectively), but with the SpeI (S) and XhoI (X) restriction endonuclease sites inserted on either side of the repeat region.
PgCS/PbRR parasites contain the PgCS N-terminal and C-terminal regions (grey boxes) and the PbCS repeat region (white box).
PbCS/PgCT parasites carry the PbCS N-terminal and repeat regions (white boxes) and the PgCS C-terminal region (grey box).

Other mutants
RMgm-770: A mutant with the endogenous CSP replaced by a chimeric CSP: N- and C-terminal regions of P. galinaceum CSP and the repeat region of P. berghei CSP
RMgm-771: A mutant with the endogenous CSP replaced by a chimeric CSP: the C-terminal region of P. galinaceum CSP and the N-terminal and repeat regions of P. berghei CSP

 


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0403200
Gene Model P. falciparum ortholog PF3D7_0304600
Gene productcircumsporozoite (CS) protein
Gene product: Alternative nameCS; CSP
Details of the genetic modification
Short description of the mutationEndogenous CS replaced by CS of P. galinaceum with SpeI & XhoI sites flanking the repeat region
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/constructPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid ApaI
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe targeting construct pPgCSSX, generated in this study contains the following structural elements: (i) the first 1,130 nucleotides of the PbCS 5’UTR sequence immediately upstream of the start codon; (ii) PgCS coding sequence and (iii) the first 1,150 nucleotides of the PbCS 3’ UTR sequence immediately downstream of its stop codon, in which the T. gondii dihydrofolate reductase/thymidylate synthase (TgDHFR/TS) drug selectable marker cassette (5,150 bp) was inserted at its HindIII site. The construct was generated from a targeting construct, pPgCS (RMgm-74) which contains the full PgCS coding sequence.

In construct pPgCSSX, SpeI and XhoI restriction sites were introduced by site-directed mutagenesis into the PgCS sequence in order to mediate exchange of the PgCS repeat region with the homologous sequence of P. berghei. The SpeI site was inserted immediately downstream of the PgCS RI core sequence NLNQP using primers For1 5’-GAGAAAATGTTGTGAATCTTAATCAACCAACTAGTGTTGGAGGAAATGGTGGTGTTCAACCTGCTG-3’ (SpeI is underlined) and Rev1 complementary to the forward primer. The XhoI restriction site was inserted after the PgCS repeat region and before RII using primers For2 5’-CTGAAGAAGAAAAGGAGGATGAACCAATACCAGATCTCGAGCCAACTCAAGAAGAAATAGATAAATATTTAAAAAG-3’ (XhoI is underlined) and Rev2 complementary to the forward primer.

The targeting construct was designed to direct the double cross-over event between the 1.13 kb sequence of the PbCS 5’ untranslated region (UTR) and the 0.85 kb sequence of the PbCS 3’ UTR in the linearized plasmid and their corresponding sequences in the PbCS locus. Plasmids pPgCSSX was digested with ApaI to release the 8.6 kb targeting insert from the plasmid backbone.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6